Annet Insurance (AWH.us) stock experienced significant volatility, with its price plummeting by 7.41%. The stock is currently trading at $0.75 per share with a trading volume of 23,104 shares and a turnover rate of 0.14%. The stock has a price fluctuation rate of 2.59%.
Recent financial reports reveal that Annet Insurance generated $2.42 million in revenue but incurred a net loss of $3.53 million. The company's earnings per share (EPS) are -$0.28, with a gross profit of $1.42 million, translating to a price-to-earnings (P/E) ratio of -0.54. No institutional recommendations for buying, holding, or selling the stock are currently available.
Within the life sciences sector, where Annet Insurance operates, the overall decline is 0.61%. Other stocks in this sector showed varied performances. Prenetics Global Limited, Volitionrx Limited, and 23Andme Holding Co. exhibited notable gains, while Applied Dna Sciences, Inc., Ispecimen Inc., and Mainz Biomed N.V. showed higher trading activity with turnover rates of 150.49%, 6.75%, and 4.75%, respectively. Significant price fluctuations were observed in Prenetics Global Limited (35.19%), Applied Dna Sciences, Inc. (21.50%), and Personalis, Inc. (10.78%).
Annet Insurance, known as Aspira Women's Health Inc, specializes in the development and commercialization of diagnostic tests for gynecological diseases. Their product line includes OvaSuite, a series of blood tests using proprietary algorithms combined with patient characteristics; OvaWatch, designed to assess the risk of ovarian cancer in women with adnexal masses; and Ova1Plus, a combination of two FDA-approved tests for women planning pelvic mass surgery.
